Bioprinting Neural Systems to Model Central Nervous System Diseases

To date, pharmaceutical progresses in central nervous system (CNS) diseases are clearly hampered by the lack of suitable disease models. Indeed, animal models do not faithfully represent human neurodegenerative processes and human in vitro 2D cell culture systems cannot recapitulate the in vivo comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Boning, Bessler, Nils, Figler, Kianti, Buchholz, Maj‐Britt, Rios, Anne C., Malda, Jos, Levato, Riccardo, Caiazzo, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Progress Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444304/
https://www.ncbi.nlm.nih.gov/pubmed/34566552
http://dx.doi.org/10.1002/adfm.201910250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444304/
https://www.ncbi.nlm.nih.gov/pubmed/34566552
http://dx.doi.org/10.1002/adfm.201910250

Ejemplares similares